| Synonyms: | |
| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 2225PI3MOV |
Physicochemical Descriptors
| Property Name | Value | |
|---|---|---|
| Molecular Formula | C9H9HgNaO2S | |
| Molecular Weight | 404.82 | |
| AlogP | None | |
| Hydrogen Bond Acceptor | None | |
| Hydrogen Bond Donor | None | |
| Number of Rotational Bond | None | |
| Polar Surface Area | None | |
| Molecular species | None | |
| Aromatic Rings | None | |
| Heavy Atoms | None |
Pharmacology
| Action | Mechanism of Action | Reference | |
|---|---|---|---|
| None | Antimicrobial preservative, used in vaccines | FDA |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | ||
|---|---|---|---|---|---|---|---|
|
Enzyme
Lyase
|
- | - | - | 10900-10900 | - | ||
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 704 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference | ||
|---|---|---|---|---|---|
| Hepatitis B, Chronic | 3 | D019694 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL508338 |
| FDA SRS | 2225PI3MOV |
| PubChem | 16684434 |
CONTENTS